Core Viewpoint - The article highlights promotional membership offers and educational courses related to investment banking and corporate finance, emphasizing significant discounts and a variety of learning opportunities for professionals in the field [2][4][6]. Membership Offers - Various membership options are available at discounted prices, including: - Annual Card: ¥4099, now ¥2799 - Semi-Annual Card: ¥2599, now ¥1799 - Honor Card: ¥1499, now ¥999 - Monthly Card: ¥699, now ¥599 [1]. Educational Courses - A range of courses is offered for free or at reduced prices, covering essential topics in investment banking and corporate finance, such as: - Mergers and Acquisitions Practicalities - Corporate Compliance Practices - Private Equity Fund Practices - AI Applications in Investment Banking [4][7][8]. - Specific courses include: - Mergers and Acquisitions with 140 case studies (4.9 hours) at ¥199.5 - Corporate Governance Compliance Issues (1.5 hours) at ¥84.5 - Financial Valuation Modeling from beginner to advanced (7.4 hours) at ¥149.5 [7][8]. Promotional Period - The promotional period for membership and courses runs from June 19 to June 26, with special pricing for two-year memberships at ¥3299 [2][8].

企业在境外进行矿产资源和其他产业投资时，需要编写可行性研究报告上报发改委及相关部门，以获得境外投资核准。另申 请中国进出口银行境外投资重点项目信贷支持时，也需要编制可行性研究报告。 可研报告从事一种经济活动(投资)之前，从政策法规、市场供求、到产品方案、生产规模、建设方案、财务效益、经济效益等 方面及社会各种环境因素进行全面调查、研究、分析，筛选确定项目各种有利与不利因素、项目各方面是否可行、估计项目 成功率大小、财务经济效益和社会效果程度，为决策者及相关单位提供决策分析的基础性研究成果资料。主要用途如下： 一、用于企业融资、对外招商合作 此目的可研报告通常要求市场分析准确、投资方案合理、并提供竞争分析、营销计划、管理方案、技术研发等实际运作方案 等。 二、用于国家发展和改革委立项 此目的可研报告是根据《中华人民共和国行政许可法》和《国务院对确需保留的行政审批项目设定行政许可的决定》而编 写，是大型基础设施项目立项的基础文件，发改委根据可行性研究报告进行核准、备案或批复，决定某个项目是否实施。另 注意，对于核准类项目，项目单位需在可研报告基础上编制项目申请报告，以项目申请报告为主材料，可研报告作为附件进 行项 ...

证券代码：600026 证券简称：中远海能 公告编号：2025-034 中远海运能源运输股份有限公司 关于申请注册发行中期票据的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 重要内容提示： 根据中远海运能源运输股份有限公司（简称"公司"）股东大会批准，公司 于 2022 年 8 月获准人民币 50 亿元中期票据注册，截止 2024 年 8 月末前述中期 票据注册有效期已经届满、额度已失效。为了保持公司融资渠道的多元化和延续 性，为公司可持续发展筹措中长期资金，不断优化融资结构、降控成本，根据《中 华人民共和国公司法》《银行间债券市场非金融企业债务融资工具管理办法》等 法律、法规的规定，公司拟向中国银行间市场交易商协会申请注册新一期中期票 据，注册总额与前一期保持一致（即不超过人民币 50 亿元）。现将具体情况公 告如下： 一、 本次中期票据的注册发行方案 （一）发行主体：中远海运能源运输股份有限公司； （二）注册规模：总额不超过人民币 50 亿元（含 50 亿元），最终发行规模 将以公司在中国银行间市场交易商协会取得 ...

Policy Developments - The National Medical Products Administration (NMPA) held a meeting on May 28 to discuss the "Clearing Source" action in the drug distribution sector, emphasizing strict enforcement of regulations and collaboration across departments to ensure drug quality and safety [2]. Drug and Device Approvals - Novartis announced on May 28 that its anti-VEGF monoclonal antibody, Brolucizumab, has been approved by the NMPA for the treatment of diabetic macular edema (DME), allowing for injections every three months after the loading phase [4]. - On the same day, the NMPA accepted the new drug application (NDA) for Rocbrutinib, a fourth-generation BTK inhibitor developed by LuPeng Pharmaceutical, which is intended for adult patients with mantle cell lymphoma (MCL) who have previously received BTK inhibitor treatment [5]. Capital Market Activities - Zhenmai Bio completed a C+ round financing of 280 million yuan on May 28, with participation from multiple investors, aiming to focus on "commercial ecosystem construction" and "global expansion" [7]. Industry Events - On May 27, Anmai Bio announced a global licensing agreement with Juri Biosciences for the development of KLK2 and CD3 T-cell engaging molecules for metastatic prostate cancer, with potential payments up to 210 million USD [9]. - Eli Lilly announced on May 27 that it will acquire SiteOne Therapeutics, a startup focused on developing sodium channel inhibitors for pain management, with a total deal value of up to 1 billion USD [10]. Regulatory and Compliance Issues - ST Longjin announced on May 28 that it received a decision from the Shenzhen Stock Exchange to terminate its stock listing, effective June 27, 2025, due to non-compliance with listing rules [12]. - ST Jiyuan's stock will be delisted on May 29, 2025, after failing to maintain a closing price above 1 yuan for 20 consecutive trading days [14]. - ST Suwu reported on May 28 that it is under investigation by the China Securities Regulatory Commission (CSRC) for information disclosure violations, but its daily operations remain normal [15]. - Jiaying Pharmaceutical announced on May 28 that it is under investigation by the CSRC for suspected information disclosure violations and will cooperate with the regulatory body [16].

Group 1 - The core viewpoint is that the financial system in Henan Province is intensifying efforts to address the financing difficulties faced by enterprises, particularly small and private businesses, through innovative mechanisms and practical actions [1] - As of May 15, the financing coordination mechanism for small and micro enterprises in Henan Province has resulted in a new credit issuance of 820.198 billion yuan and new loans of 757.289 billion yuan [1] - Financial institutions have visited a total of 7.3488 million small and micro enterprises and individual businesses to ensure comprehensive coverage of financing needs [1] Group 2 - Financial institutions are focusing on supporting the transformation and upgrading of the manufacturing industry, providing specialized support for traditional industries to become more intelligent, green, and technologically advanced [2] - As of the end of April, 54.91% of new corporate loans in the province were directed towards private enterprises, with the number of private enterprise loan accounts reaching 34,900 and the loan balance amounting to 2.54 trillion yuan [2] - The financial regulatory department is enhancing the monitoring system for private enterprise loans and guiding banks to set annual service targets specifically for private and small enterprises [2]

Financial Highlights - As of the end of April, Dongguan's total loans reached 1.9959 trillion yuan, a year-on-year increase of 2.5%, making it the top city in Guangdong province for loan growth [1][2] - The total deposits in Dongguan amounted to 2.8537 trillion yuan, reflecting a year-on-year growth of 6.6% [1][2] - Small and micro enterprise loans in Dongguan reached 424.6 billion yuan, up 17.4% year-on-year, maintaining the highest scale among cities in Guangdong [2] Corporate Developments - Seven high-growth enterprises from Dongguan successfully listed on the Guangdong Equity Exchange, marking their entry into the capital market [3] - Qunshang Co. faced a court ruling where 13.46 million shares were transferred to China Orient Asset Management after failed auctions [4] - Shanghai Industrial Holdings announced the sale of 19.47% of its stake in Guangdong Yufeng Environmental Power, with a book value of approximately 2.386 billion HKD [5] - Jinlong Co. terminated the sale of its stake in Zhongshan Securities to avoid potential regulatory issues, while continuing the sale of its shares in Dongguan Securities [6] - Dongguan Holdings completed the transfer of a 22.2069% stake in Dongguan Trust for 1.428 billion yuan, recovering all transfer payments [7] - Zhongsheng Pharmaceutical received approval for its innovative flu drug, Anladiwei, which is expected to enhance its market competitiveness [9] - Xiangxin Technology announced plans for several executives to reduce their shareholdings due to personal financial needs, despite a revenue increase in the first quarter [10]

Group 1 - Shenzhen Municipal Political Consultative Conference has initiated key research to promote the healthy and high-quality development of the private economy [1] - Four discussion sessions were held focusing on fair competition, factor support, rights protection, and individual economy, gathering opinions and suggestions from enterprises and industry associations [1] - In the "Fair Competition Group," discussions centered on resource allocation between large and small enterprises and collaboration between private and state-owned enterprises [1] Group 2 - The "Factor Support Group" highlighted financing issues, with new models like "credit + loan" and "data + guarantee" being seen as promising solutions [1] - The "Rights Protection Group" discussed experiences in enterprise support and judicial assistance, emphasizing the need for intellectual property protection and business secret safeguards [1] - The "Individual Economy Group" focused on implementing national tax reduction policies and enhancing cross-border e-commerce [1] Group 3 - There is a growing discussion on supporting enterprises going overseas, with suggestions for government to enhance policy coordination and provide legal and tax consulting services [2] - Financing challenges for medium-sized enterprises were noted, with a call for tailored credit policies to address their unique needs [2] - Concerns regarding the "industrial upgrading" model were raised, with recommendations for timely policy support to accommodate innovative enterprises [2]

Core Viewpoint - The company plans to issue short-term financing bonds and medium-term notes to expand financing channels and reduce costs, with a total issuance limit of up to 15 billion yuan for short-term bonds and 8 billion yuan for medium-term notes [1][2][3] Short-term Financing Bonds Issuance Plan - Issuer: Thinkwell (Shanghai) Electronic Technology Co., Ltd. - Issuance Date: To be determined based on market conditions and funding needs - Issuance Scale: Up to 15 billion yuan, subject to the final amount as per the registration notice from the trading association - Issuance Term: To be determined based on market conditions and funding needs - Issuance Rate: To be determined based on market conditions at the time of issuance - Fund Usage: For production and operational activities, including debt repayment and working capital [1][2] Medium-term Notes Issuance Plan - Issuer: Thinkwell (Shanghai) Electronic Technology Co., Ltd. - Issuance Date: To be determined based on market conditions and funding needs - Issuance Scale: Up to 8 billion yuan, subject to the final amount as per the registration notice from the trading association - Issuance Term: To be determined based on market conditions and funding needs - Issuance Rate: To be determined based on market conditions at the time of issuance - Fund Usage: For production and operational activities, including debt repayment and working capital [2] Authorization Matters - The company seeks authorization from the shareholders' meeting for the board of directors to manage the issuance of short-term financing bonds and medium-term notes, including decisions on issuance timing, scale, types, terms, rates, and fund usage [2][3] Impact of the Issuance on the Company - The issuance of short-term financing bonds and medium-term notes is expected to broaden financing channels, optimize financing structure, enhance liquidity management, and meet the funding needs for the company's rapid development, aligning with the overall interests of the company and shareholders [3]

Core Viewpoint - The company plans to issue up to 1.5 billion yuan in short-term financing bonds and up to 800 million yuan in medium-term notes to broaden financing channels and reduce costs, addressing the funding needs for rapid development [1] Financing Plan - The issuance will be registered with the China Interbank Market Dealers Association and is subject to approval by the shareholders' meeting [1] - The issuance plan includes details on the issuer, issuance date, scale, term, interest rate, and use of funds [1] Purpose of Funds - The funds raised will be used for operational activities, including repaying existing debts and supplementing working capital [1] - The interest rate for the issuance will be determined based on market conditions [1]

Core Viewpoint - The company plans to apply for the registration and issuance of medium-term notes not exceeding 300 million yuan, with a maturity of up to 5 years, to broaden financing channels and reduce financing costs [1] Group 1 - The issuance has been approved by the company's fourth board of directors' sixth meeting and will be submitted for shareholder meeting approval [1] - The funds raised will be used for research and development investments and to supplement working capital in compliance with national laws and regulations [1]